%0 Journal Article
%T Chronic Spontaneous Urticaria: Quality of Life and Economic Impacts.
%A Keller L
%A Stitt J
%J Immunol Allergy Clin North Am
%V 44
%N 3
%D 2024 Aug
%M 38937009
%F 3.152
%R 10.1016/j.iac.2024.03.004
%X This study focuses on quality of life (QoL) assessment in chronic urticaria, delving into tools, disease-specific measures, and its profound impact. With expanding therapeutic options, understanding QoL becomes crucial. QoL measures often involve comparisons of patient-reported outcomes in addition to quantitative measures of disease control. Emerging tools include the Urticaria Activity and Impact Measure, which may provide a balanced evaluation. In addition to discussions of the various QoL measures, the psychological impact of chronic urticaria are highlighted, covering emotional burden, stress, and psychiatric comorbidities. Finally, the economic impacts reveal escalating health care costs and cost-effectiveness considerations of therapies like omalizumab.